Trial Profile
Lack of effect of the glucagon-like peptide-1 receptor agonist liraglutide on psoriasis in glucose-tolerant patients--a randomized placebo-controlled trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2016
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Therapeutic Use
- 02 Feb 2016 New trial record